Correlation Between Monte Rosa and Cullinan Oncology

Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Monte Rosa Therapeutics and Cullinan Oncology LLC, you can compare the effects of market volatilities on Monte Rosa and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Cullinan Oncology.

Diversification Opportunities for Monte Rosa and Cullinan Oncology

0.17

Correlation Coefficient

Monte Rosa  Cullinan Oncology

Average diversification

The 3 months correlation between Monte and Cullinan is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Monte Rosa i.e., Monte Rosa and Cullinan Oncology go up and down completely randomly.

Pair Corralation between Monte Rosa and Cullinan Oncology

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 1.19 times more return on investment than Cullinan Oncology. However, Monte Rosa is 1.19 times more volatile than Cullinan Oncology LLC. It trades about 0.12 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about 0.03 per unit of risk. If you would invest  385.00  in Monte Rosa Therapeutics on May 7, 2025 and sell it today you would earn a total of  103.00  from holding Monte Rosa Therapeutics or generate 26.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Monte Rosa Therapeutics  vs.  Cullinan Oncology LLC

Monte Rosa Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cullinan Oncology LLC

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cullinan Oncology LLC are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Cullinan Oncology may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Monte Rosa and Cullinan Oncology

The main advantage of trading using opposite Monte Rosa and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.

The idea behind Monte Rosa Therapeutics and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.